Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.11

-2.6%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ian@SI who wrote (20793)	8/9/2006 11:08:51 PM
From: Biomaven	Read Replies (3) of 52153

Perhaps I'll change my Lipitor Sales estimate to an increase of 5-10%. :^) Coincidentally I received in the mail today a package from my insurance company consisting of a pitch for me to switch to a generic statin and explaining how much money I could save. Even included a mostly-filled out prescription blank for me to send to my doctor. I don't think there's ever been a push like this before. The insurance companies should of course have done this with Prilosec but they were too shortsighted and went with the OTC push instead. If they were really smart they would sponsor a trial of 40mg prilosec vs 20 mg Nexium or the standard dose of Protonix - I bet they could show equivalence and then mount the same sort of push. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next